Palmieri, C ORCID: 0000-0001-9496-2718
(2015)
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.
Lancet Oncol..
Text
Earl et al 2015.pdf - Published version Download (296kB) |
Item Type: | Article |
---|---|
Depositing User: | Symplectic Admin |
Date Deposited: | 30 Jul 2018 08:48 |
Last Modified: | 19 Jan 2023 01:30 |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3024349 |
Share
CORE (COnnecting REpositories)